Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Japanese non-invasive blood glucose detection technology company seeks financing.

Project region Japan
Industry Biomedicine
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Senior Associate, International Business Advisory

Project highlights intelligent wearable device technology supplier - spectrometer - USD 10 million financing obtained
Project description

The Japanese company is an intelligent wearable device technology supplier, which can provide detection solutions for blood pressure, heartbeat, body temperature, blood oxygen and other physical characteristics. The non-interventional blood glucose detection developed by the company can use the spectrometer to measure the blood glucose level of users in a non-invasive manner. At present, the company has obtained USD 10 million financing from Taisho Pharmaceutical Group and Alfresa Holdings Corporation. Now it seeks financing.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive